Phenyl - Generic Drug Details
✉ Email this page to a colleague
US Patents and Regulatory Information for Phenyl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Milla Pharms | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 211081-002 | Jul 17, 2020 | AP1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Gland | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 218129-002 | Dec 18, 2024 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Eyenovia | MYDCOMBI | phenylephrine hydrochloride; tropicamide | SPRAY, METERED;OPHTHALMIC | 215352-001 | May 5, 2023 | DISCN | Yes | No | 11,398,306 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Accord Hlthcare | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 213237-002 | Jul 1, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | IMMPHENTIV | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 203826-005 | Mar 9, 2023 | RX | Yes | Yes | 11,213,480 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Gland | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 211920-001 | Jun 5, 2020 | AP1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
